The USFDA has approved a device called EndoRotor to debride necrotic tissue from patients suffering from walled-off pancreatic necrosis . The device is the first to be approved by the USFDA for the said indication. The EndoRotor device is used in direct endoscopic necrosectomy. It consists of a power console, specimen trap, single-use catheter, and foot control. The procedure involves two steps: Creating a portal between the stomach and the necrotic cavity with the help of a metallic stent.
The portal is also inclusive of a standard endoscope to guide the procedure. Placing the EndoRotor through the working channel of the endoscope that resects and removes the dead tissues. The EndoRotor system is contraindicated in patients with known or suspected pancreatic cancer and pseudoaneurysm. Hematemesis, deep vein thrombosis, and pancreatitis are some of the reported side effects of the…
